Clinical Trial Update: Efficacy and Safety of Concomitant Montelukast Sodium and Levocetirizine Dihydrochloride in Perennial Allergic Rhinitis (PAR) Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of concomitant montelukast sodium and levocetirizine dihydrochloride in perennial allergic rhinitis has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perennial Allergic Rhinitis

Drugs mentioned

• Levocetirizine dihydrochloride (LEVOCETIRIZINE DIHYDROCHLORIDE)
• Montelukast Sodium (Montelukast Sodium)

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Perennial Allergic Rhinitis | Phase 3 | Status: COMPLETED